Guggenheim inicia cobertura da Stoke Therapeutics com recomendação de compra para medicamento contra síndrome de Dravet
Stoke Therapeutics, Inc. (STOK) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:STOK) 2026-01-13